Skip to main content
. Author manuscript; available in PMC: 2015 Apr 7.
Published in final edited form as: Int J Obes (Lond). 2013 Dec 4;38(8):1104–1109. doi: 10.1038/ijo.2013.227

Table 1.

Annualised parameter estimates used in Markov model

Parameter Annual Probabilities Source
Standard Care Commercial Program
Probability of developing diabetes for normal health state 0.004 (0.002) 0.004 (0.002) AusDiab Report 2005 12
Probability of developing diabetes for overweight health state 0.008 (0.003) 0.008 (0.003) AusDiab Report 2005 12
Probability of developing diabetes for obese health state 0.016 (0.004) 0.016 (0.004) AusDiab Report 2005 12
Mortality rate for those with type 2 diabetes (age 47-99 years) 0.008-0.328 0.008-0.328 Magliano et al 14, Keating et al 13
Mortality rate for those without type 2 diabetes (age 47-99 years) 0.002-0.332 0.002-0.332 Magliano et al 14, Keating et al 13
Probability of healthy BMI range (start of trial) 0 0 RCT
Probability of overweight BMI range (start of trial) 0.331 0.331 RCT
Probability of obese BMI range (start of trial) 0.603 0.603 RCT
Probability of type 2 diabetes (start of trial) 0.066 0.066 RCT
Probability of obese BMI range at start of trial to overweight BMI range at 12 months 0.201 (0.375) 0.439 (0.305) RCT
Probability of overweight BMI range at start of trial to healthy BMI range at 12 months 0.188 (0.639) 0.414 (0.398) RCT
Probability of healthy BMI range at 12 months to overweight BMI range at 24 months 0.320 (0.680) 0.509 (0.346) RCT
Probability of overweight BMI range at 12 months to obese BMI range at 24 months 0.099 (0.889) 0.286 (0.571) RCT
Probability of diabetes remission at 12 months 0.074 0.167 RCT
Quality of life adjustments
Normal health state 0.81(0.07) 0.81(0.07) RCT
Overweight health state 0.81 (0.06) 0.81 (0.06) RCT
Obese health state 0.78 (0.07) 0.78 (0.07) RCT
Type 2 diabetes 0.75 (0.10) 0.75 (0.10) RCT
Start age 47.4 47.4 RCT 2

Values are presented as mean (SD). SD – standard deviation; as tested in the probabilistic sensitivity analysis. RCT – randomised controlled trial; BMI – Body Mass Index